Companies & Industry »Company News»Company News Details
Company News Details

BSE   17 Apr 14 | 12:00 AM

972.65 -0.45 (-0.05%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 532321
Face Value: N.A.

NSE   17 Apr 14 | 12:00 AM

973.15 -0.75 (-0.08%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: CADILAHC
Performance
1 Week : Rs 966.90 (0.59%)
1 Month : Rs 970.95 (0.18%)
1 Year : Rs 763.30 (27.43%)
change companytradenow
Back

Cadila's stock rising: Credit Suisse

Reuters / 18 Jul 12 | 11:50 AM

Credit Suisse initiates coverage on Cadila Healthcare with an "outperform" rating and a target price of Rs 970.

Investment bank says the midcap drug maker has demonstrated "strong execution" in the United States, with a portfolio mix focusing on low competition products such as nasal sprays and injectable drugs.

USFDA approval of its facilities in Moraiya, part of Gujarat, will re-start new approvals of its drugs in the US market, Credit Suisse adds.

"Cadila is moving up the value-chain with the launch of difficult-to formulate products and its strong execution record provides multi-year growth visibility."

Sensex

Company Price Gain (%)
Hindalco Inds.141.304.40
Tata Motors428.654.24
ICICI Bank1,262.003.25
B H E L181.053.10
St Bk of India2,017.802.96

Online Portfolio

You can create Online Portfolio here using the below button.